SEC 13F Intelligence

Lion Point Capital, LP / DYN

Lion Point Capital, LP’s Dyne Therapeutics Inc Position

Does Lion Point Capital, LP own Dyne Therapeutics Inc (DYN)? Yes18.0K shares worth $326,340 (+1.95% of its 13F portfolio) as of Q1 2026.

Position Value
$326,340
Q1 2026
Shares
18.0K
% of Portfolio
+1.95%
Quarters Held
2
currently held

Position History DYN

Reported value by quarter
Q4 ’25: $352,080Q4 ’25Q1 ’26: $326,340Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202618.0K$326,340+1.95%
Q4 202518.0K$352,080+1.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of DYN.